GC-MS-based plasma metabolomic investigations of morphine dependent rats at different states of euphoria, tolerance and naloxone-precipitated withdrawal

[1]  A. Zhang,et al.  Metabolomics and Its Potential in Drug Discovery and Development From TCM , 2015 .

[2]  Y. Wang,et al.  High dose remifentanil increases myocardial oxidative stress and compromises remifentanil infarct-sparing effects in rats. , 2013, European journal of pharmacology.

[3]  K. Kovács,et al.  Differential Changes in Expression of Stress- and Metabolic-Related Neuropeptides in the Rat Hypothalamus during Morphine Dependence and Withdrawal , 2013, PloS one.

[4]  J. Idle,et al.  Metabolomics and its potential in drug development. , 2013, Biochemical pharmacology.

[5]  L. Pardo,et al.  Crystal structure of the μ-opioid receptor bound to a morphinan antagonist , 2012, Nature.

[6]  Bryan L. Roth,et al.  Structure of the human kappa opioid receptor in complex with JDTic , 2012, Nature.

[7]  W. Koek,et al.  Morphine-induced motor stimulation, motor incoordination, and hypothermia in adolescent and adult mice , 2012, Psychopharmacology.

[8]  Sabita Roy,et al.  Morphine Induces Splenocyte Trafficking into the CNS , 2011, Journal of Neuroimmune Pharmacology.

[9]  H. Loh,et al.  Cholesterol Regulates μ-Opioid Receptor-Induced β-Arrestin 2 Translocation to Membrane Lipid Rafts , 2011, Molecular Pharmacology.

[10]  Xian-Zhong Yan,et al.  A metabolomic analysis of the toxicity of Aconitum sp. alkaloids in rats using gas chromatography/mass spectrometry. , 2009, Rapid communications in mass spectrometry : RCM.

[11]  Y. Li,et al.  Dynamic metabonomic analysis of BALB/C mice with different outcomes after D‐galactosamine/lipopolysaccharide–induced fulminant hepatic failure , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[12]  J. Whistler,et al.  The role of mu opioid receptor desensitization and endocytosis in morphine tolerance and dependence , 2007, Current Opinion in Neurobiology.

[13]  Feng Liu,et al.  Metabolic profiling analysis of a D-galactosamine/lipopolysaccharide-induced mouse model of fulminant hepatic failure. , 2007, Journal of proteome research.

[14]  P. Singhal,et al.  Morphine-Induced Degradation of the Host Defense Barrier , 2006, Digestive Diseases and Sciences.

[15]  Graeme Henderson,et al.  75 years of opioid research: the exciting but vain quest for the Holy Grail , 2006, British journal of pharmacology.

[16]  F. Moody,et al.  The effect of morphine on mast cell-mediated mucosal permeability. , 2006, Surgery.

[17]  M. Connor,et al.  Opioids: cellular mechanisms of tolerance and physical dependence. , 2005, Current opinion in pharmacology.

[18]  Cynthia Ludwig,et al.  Gastrointestinal tract , 2005, The American Journal of Digestive Diseases.

[19]  P. Lisowski,et al.  [Determination of ascorbic and dehydroascorbic acid concentration using HPLC method in smokers with stable coronary artery disease scheduled for coronary artery bypass grafting (CABG)]. , 2005, Przeglad lekarski.

[20]  C. Sternini,et al.  The opioid system in the gastrointestinal tract , 2004, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[21]  M. Branchey,et al.  Association Between Low Plasma Levels of Cholesterol and Relapse in Cocaine Addicts , 2003, Psychosomatic medicine.

[22]  C. Ferran,et al.  A20 protects mice from D‐galactosamine/lipopolysaccharide acute toxic lethal hepatitis , 2002, Hepatology.

[23]  T. Eisenstein,et al.  Morphine Inhibits Mucosal Antibody Responses and TGF-β mRNA in Gut-Associated Lymphoid Tissue Following Oral Cholera Toxin in Mice1 , 2001, The Journal of Immunology.

[24]  J T Williams,et al.  Cellular and synaptic adaptations mediating opioid dependence. , 2001, Physiological reviews.

[25]  O. Fiehn,et al.  Metabolite profiling for plant functional genomics , 2000, Nature Biotechnology.

[26]  H. Akil,et al.  Cellular localization and distribution of the cloned mu and kappa opioid receptors in rat gastrointestinal tract , 1997, Neuroscience.

[27]  D. Lysle,et al.  Tolerance development to morphine-induced alterations of immune status. , 1997, Drug and alcohol dependence.

[28]  G. Henderson,et al.  The orphan opioid receptor and its endogenous ligand--nociceptin/orphanin FQ. , 1997, Trends in pharmacological sciences.

[29]  K. Befort,et al.  The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Lei Yu,et al.  Molecular cloning and functional expression of a mu opioid receptor from rat brain , 1994, Regulatory Peptides.

[31]  K. Befort,et al.  The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[32]  R. Edwards,et al.  Cloning of a delta opioid receptor by functional expression. , 1992, Science.

[33]  J. Holaday,et al.  Immunosuppressive effects of chronic morphine treatment in mice. , 1987, Life sciences.

[34]  T. Hedner,et al.  Opioids and opioid receptors in peripheral tissues. , 1987, Scandinavian journal of gastroenterology. Supplement.

[35]  C. Mcintosh,et al.  Autoradiographic Localization of μ- and δ-Type Opioid Receptors in the Gastrointestinal Tract of the Rat and Guinea Pig , 1986 .

[36]  C. Mcintosh,et al.  Autoradiographic localization of mu- and delta-type opioid receptors in the gastrointestinal tract of the rat and guinea pig. , 1986, Gastroenterology.

[37]  R. Pacifici,et al.  Morphine and methadone impact on human phagocytic physiology. , 1985, International journal of immunopharmacology.

[38]  C. Kornetsky,et al.  An animal model for opiate induced euphoria and analgesia. , 1982, Therapeutische Umschau. Revue thérapeutique.

[39]  C. A. Thomas,et al.  Molecular cloning. , 1977, Advances in pathobiology.

[40]  C. Schneider,et al.  Jumping after naloxone precipitated withdrawal of chronic morphine in the rat. , 1971, British journal of pharmacology.

[41]  Sancilio Lf,et al.  Morphine dependent rats as a model for evaluating potential addiction liability of analgesic compounds. , 1970 .

[42]  L. Sancilio,et al.  Morphine dependent rats as a model for evaluating potential addiction liability of analgesic compounds. , 1970, Archives internationales de pharmacodynamie et de therapie.

[43]  A. Hodgkinson,et al.  Plasma oxalic acid and calcium levels in oxalate poisoning , 1967, Journal of clinical pathology.